1. Home
  2. CRL vs BIO Comparison

CRL vs BIO Comparison

Compare CRL & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$226.47

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$312.84

Market Cap

8.7B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRL
BIO
Founded
1947
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.7B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
CRL
BIO
Price
$226.47
$312.84
Analyst Decision
Buy
Strong Buy
Analyst Count
14
4
Target Price
$203.58
$358.50
AVG Volume (30 Days)
679.5K
184.0K
Earning Date
02-18-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,023,704,000.00
$2,557,500,000.00
Revenue This Year
N/A
$1.62
Revenue Next Year
$1.70
$2.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$91.86
$211.43
52 Week High
$228.88
$373.69

Technical Indicators

Market Signals
Indicator
CRL
BIO
Relative Strength Index (RSI) 70.58 47.12
Support Level $216.03 $306.52
Resistance Level $227.51 $328.56
Average True Range (ATR) 7.73 9.16
MACD 0.14 -0.38
Stochastic Oscillator 91.22 40.11

Price Performance

Historical Comparison
CRL
BIO

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: